What’s The Plan? US FDA Drug Development Tool Qualification Process Requires “Cultural Change”

 
• By Michael McCaughan
  
Binoculars hang on a wooden fence background
Sponsors and the US FDA are going to need to change the way they look at biomarker development.

More from Clinical Trials

More from R&D